1. Efficacy and safety of piecemeal submucosal tunneling endoscopic resection for giant esophageal leiomyoma.
- Author
-
Li, Authors Xin, Liu, En, Xie, Xia, Peng, Xue, Nie, Xu-biao, Li, Jian-jun, Gao, Yong, Liu, Lu, Bai, Jian-ying, Wang, Tong-chuan, and Fan, Chao-qiang
- Abstract
Giant esophageal leiomyoma usually requires a thoracotomy or thoracoscopic surgery, which is more invasive than an endoscopic treatment. The purpose of this study is to evaluate the efficacy and safety of piecemeal submucosal tunneling endoscopic resection (P-STER) for giant leiomyoma originating from the muscularis propria (MP) layer of the esophagus. This is a retrospective study. Patients with giant esophageal leiomyoma (transverse diameter ≥ 3 cm) who underwent P-STER were enrolled from November 2012 to May 2023. Clinical data and results were investigated. A total of 16 patients were enrolled for analysis. The lesion mean transverse diameter and longitudinal diameter were 4.22 ± 1.20 cm and 6.20 ± 1.57 cm, respectively. Our mean operation time was 195.38 ± 84.99 min. The mean number of piecemeal resected was 4.31 ± 2.36. An adverse event noted was an esophageal fistula that occurred in one case (6.25%) and was treated conservatively. The mean length of hospital stay was around 11.81 ± 7.30 days. The mean total hospitalization cost was U.S. dollars (USD) $5976.50 ± 2866.39. No recurrence or metastasis was found during the follow-up period. P-STER can be an effective and safe treatment for giant leiomyoma originating from the MP layer of the esophagus. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF